With positive results from early tests, the drone industry is hopeful that lawmakers will increase their leniency in regulating drones. With this hope come questions about what should be considered a drone-deliverable item, specifically when it comes to controlled substances like pharmaceuticals. There are many angles...
Regulatory-grade real-world evidence technology provider Aetion recently announced its acquisition of Replica Analytics. Replica Analytics is well known for creating synthetic health data through artificial intelligence programs. Replica will be able to help Aetion through its ability to preserve the utility of source data, thanks...
A two-part interview with AllStripes co-founder Nancy Yu on PatientWorthy went in depth about Yu’s background, why she started the company, and plans for the future. It begins by highlighting her interest in how science and technology interact with one another. Yu explained how growing up...
Bioinformatics company M2GEN announced a partnership with Microsoft in a move to improve and expand its data-driven solutions for research, discovery, and development of oncology therapies. The collaboration will combine M2GEN’s clinico-genomics database with Microsoft’s healthcare technologies to expand the possibilities of future cancer therapeutics. High-quality...
Be The Match BioTherapies® and Vineti announced a collaboration to create streamlined solutions that alleviate supply chain management difficulties related to cell and gene therapies. The collaboration is non-exclusive and is expected to unite the industry’s top workflow programs: Vineti’s Personalized Therapy Management® platform and...
Aetion has been selected by the European Medicines Agency to support the agency’s Quality, Efficacy, and Safety Studies on Medicines. Aetion is a health care analytics company, working to provide real-world evidence for regulators, manufacturers, and purchasers of medical treatments and technologies. The company was...
The Saama Board of Directors recently gained some highly respected leaders in Ian Read, former CEO and executive chairman of Pfizer, and Clive Meanwell, former CEO and founder of The Medicines Company. This news was revealed after a $430 million strategic investment in Saama by...
Kyruus has grown quite a bit since it first started as a hospital appointment scheduling platform, and the company aims to continue that trend with its recent acquisition of HealthSparq. With this move, the company plans to bridge the gap between providers and payers and...
Digital health company Xealth announced a recent survey examining new mothers and their expectations for digital health in comparison with the healthcare services they received. The survey was conducted among over 1,000 new or expectant mothers, with 57 percent of them showing a more favorable...
Luca Foschini, PhD, is chief data scientist and co-founder at Evidation Health. In a recent interview he discussed how artificial intelligence interacts with patient-generated data to create advancements in clinical studies for pharmaceutical and biotech companies. Smartphones and smartwatches are used daily around the world to...